Effects of acute infusion of the muscarinic cholinergic agonist arecoline on verbal memory and visuo-spatial function in dementia of the alzheimer type
- 1 January 1991
- journal article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 15 (5) , 643-648
- https://doi.org/10.1016/0278-5846(91)90054-5
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Mechanisms of cholinesterase inhibition in senile dementia of the alzheimer type: Clinical, pharmacological, and therapeutic aspectsDrug Development Research, 1988
- Relations between Neuropsychological and Cerebral Metabolic Asymmetries in Early Alzheimer's DiseaseJournal of Cerebral Blood Flow & Metabolism, 1985
- Neurotransmitter receptors in the central nervous system and aging: Pharmacological aspect (review)Experimental Gerontology, 1984
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- The 12th J. A. F. Stevenson Memorial Lecture: Aging, Alzheimer's disease, and the cholinergic systemCanadian Journal of Physiology and Pharmacology, 1984
- Cholinergic system and constructional praxis: a further study of physostigmine in Alzheimer's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1984
- Measurement of cholinergic drug effects on memory in alzheimer's diseaseNeurobiology of Aging, 1983
- No effect from double‐blind trial of physostigmine and lecithin in Alzheimer diseaseAnnals of Neurology, 1983
- Physostigmine and Arecoline: Effects of Intravenous Infusions in Alzheimer Presenile DementiaThe British Journal of Psychiatry, 1981
- “Mini-mental state”Journal of Psychiatric Research, 1975